to enjoy learning and progressing in cardiometabolic practice









Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy





Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrumVICTORIA and VICTOR Clinical Trials

Reduction of Antihypertensive Treatment in Nursing Home Residents

High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults

Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction (TARGET-FIRST)

Apixaban for Extended Treatment of Provoked Venous Thromboembolism (HI-PRO)

Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF RCT

SGLT2 inhibitors in CKD: are they really effective in all patients?

DOACs for Rheumatic Heart Disease-Associated AF Post-Bioprosthetic MVR

22nd ACC 2025 Congress Coverage: FLAVOUR II Trial

Case Discussion 124: Anticoagulation in Patients with Mitral Stenosis

23rd ACC 2025 Congress Coverage: FAME 3 Trial

19th ACC 2025 Congress Coverage: HPV Infection and Cardiovascular Disease

18th ACC 2025 Congress Coverage: SOUL Trial